These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [The mechanism(s) of alpha-(aminoethyl)-gamma-butyrolactone. In vivo studies in mice]. Kolocouris N; Fytas G; Foscolos GB; Kalliteraki I; Vamvakides A Boll Chim Farm; 1994 Sep; 133(8):516-20. PubMed ID: 7826586 [TBL] [Abstract][Full Text] [Related]
7. [Antiviral chemotherapeutic agents. XVIII. Adamantane derivatives of amphetamine. Their potential interest as autonomic and antiparkinson agents]. Runti C; De Nardo M; Fabrissin S Farmaco Sci; 1975 Apr; 30(4):260-75. PubMed ID: 241665 [TBL] [Abstract][Full Text] [Related]
8. Synthesis of 61-bis(1-adamantylcarbamoyl)-1,2-methano[60]fullerene and its antagonistic effect on haloperidol-induced catalepsy in mice. Nakazono M; Hasegawa S; Yamamoto T; Zaitsu K Bioorg Med Chem Lett; 2004 Nov; 14(22):5619-21. PubMed ID: 15482935 [TBL] [Abstract][Full Text] [Related]
9. [Effect of adamantyl quaternary ammonium derivatives on the autonomic ganglia]. Buianov VV Farmakol Toksikol; 1987; 50(6):37-41. PubMed ID: 3436421 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and pharmacological study of some new beta-(dialkylaminomethyl)- gamma-butyrolactones and their tetrahydrofuran analogues. Foscolos GB; Kolocouris N; Fytas G; Marakos P; Pouli N; Vamvakides A Farmaco; 1996 Jan; 51(1):19-26. PubMed ID: 8721757 [TBL] [Abstract][Full Text] [Related]
11. Antiviral compounds. XIII. Synthesis and anti-influenza virus activity of N-(1-adamantyl)amidinohydrazones. Nishimura T; Toku H; Fukuyasu H; Kawakami M; Kazuno Y; Sekizawa Y Kitasato Arch Exp Med; 1979 Dec; 52(1-4):15-21. PubMed ID: 261989 [No Abstract] [Full Text] [Related]
12. [Compounds with potential antitumor activity. II. N,N'-(1-Diadamantandicarboxyamides)]. Ficarra P; Ficarra R; Tommasini A; Fenech G Farmaco Sci; 1983 Jun; 38(6):418-24. PubMed ID: 6873275 [TBL] [Abstract][Full Text] [Related]
13. Identification of a highly potent vitamin D receptor antagonist: (25S)-26-adamantyl-25-hydroxy-2-methylene-22,23-didehydro-19,27-dinor-20-epi-vitamin D3 (ADMI3). Igarashi M; Yoshimoto N; Yamamoto K; Shimizu M; Ishizawa M; Makishima M; DeLuca HF; Yamada S Arch Biochem Biophys; 2007 Apr; 460(2):240-53. PubMed ID: 17214957 [TBL] [Abstract][Full Text] [Related]
14. SAR-oriented discovery of peroxisome proliferator-activated receptor pan agonist with a 4-adamantylphenyl group as a hydrophobic tail. Kasuga J; Yamasaki D; Ogura K; Shimizu M; Sato M; Makishima M; Doi T; Hashimoto Y; Miyachi H Bioorg Med Chem Lett; 2008 Feb; 18(3):1110-5. PubMed ID: 18162399 [TBL] [Abstract][Full Text] [Related]
15. Synthesis, structure and tumour necrosis factor-alpha production-enhancing properties of novel adamantylamino heterocyclic derivatives. Mauri JK; Lasek W; Górska A; Switaj T; Wamil M; Młynarczuk I; Kazimierczuk Z Anticancer Drug Des; 2001; 16(2-3):73-80. PubMed ID: 11962515 [TBL] [Abstract][Full Text] [Related]
16. Antagonist analogue of 6-[3'-(1-adamantyl)-4'-hydroxyphenyl]-2-naphthalenecarboxylic acid (AHPN) family of apoptosis inducers that effectively blocks AHPN-induced apoptosis but not cell-cycle arrest. Dawson MI; Harris DL; Liu G; Hobbs PD; Lange CW; Jong L; Bruey-Sedano N; James SY; Zhang XK; Peterson VJ; Leid M; Farhana L; Rishi AK; Fontana JA J Med Chem; 2004 Jul; 47(14):3518-36. PubMed ID: 15214780 [TBL] [Abstract][Full Text] [Related]
17. Anticonvulsant effects of phencynonate hydrochloride and other anticholinergic drugs in soman poisoning: neurochemical mechanisms. Wang YA; Zhou WX; Li JX; Liu YQ; Yue YJ; Zheng JQ; Liu KL; Ruan JX Life Sci; 2005 Nov; 78(2):210-23. PubMed ID: 16154160 [TBL] [Abstract][Full Text] [Related]
18. Synthesis, antimicrobial, and anti-inflammatory activities of novel 2-(1-adamantyl)-5-substituted-1,3,4-oxadiazoles and 2-(1-adamantylamino)-5-substituted-1,3,4-thiadiazoles. Kadi AA; El-Brollosy NR; Al-Deeb OA; Habib EE; Ibrahim TM; El-Emam AA Eur J Med Chem; 2007 Feb; 42(2):235-42. PubMed ID: 17129641 [TBL] [Abstract][Full Text] [Related]